PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,947,780 | -19.8% | 5,344,446 | 0.0% | 2.07% | +13.2% |
| Q2 2023 | $8,658,003 | -23.9% | 5,344,446 | 0.0% | 1.82% | -52.3% |
| Q1 2023 | $11,383,670 | -36.8% | 5,344,446 | 0.0% | 3.82% | -44.0% |
| Q4 2022 | $18,010,783 | +346.0% | 5,344,446 | 0.0% | 6.83% | +365.6% |
| Q3 2022 | $4,038,000 | -2.8% | 5,344,446 | 0.0% | 1.47% | +6.5% |
| Q2 2022 | $4,156,000 | -12.4% | 5,344,446 | +1.9% | 1.38% | +31.3% |
| Q1 2022 | $4,747,000 | -87.8% | 5,244,446 | +10.0% | 1.05% | -86.4% |
| Q4 2021 | $38,935,000 | – | 4,765,659 | – | 7.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |